0001104659-23-071303.txt : 20230614
0001104659-23-071303.hdr.sgml : 20230614
20230614181529
ACCESSION NUMBER: 0001104659-23-071303
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230613
FILED AS OF DATE: 20230614
DATE AS OF CHANGE: 20230614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Martell Bridget A
CENTRAL INDEX KEY: 0001629627
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39373
FILM NUMBER: 231015394
MAIL ADDRESS:
STREET 1: C/O POINT BIOPHARMA GLOBAL INC.
STREET 2: 4850 WEST 78TH STREET
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46268
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: POINT Biopharma Global Inc.
CENTRAL INDEX KEY: 0001811764
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 850800493
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4850 WEST 78TH STREET
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46268
BUSINESS PHONE: (317) 543-9957
MAIL ADDRESS:
STREET 1: 4850 WEST 78TH STREET
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46268
FORMER COMPANY:
FORMER CONFORMED NAME: Therapeutics Acquisition Corp.
DATE OF NAME CHANGE: 20200511
4
1
tm2318760-1_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-06-13
0
0001811764
POINT Biopharma Global Inc.
PNT
0001629627
Martell Bridget A
4850 WEST 78TH STREET
INDIANAPOLIS
IN
46268
1
0
0
0
0
Stock Option (Right to Buy)
10.08
2023-06-13
4
A
0
80503
0.00
A
2029-06-13
Common Stock
80503
80503
D
The option will vest 100% on the first anniversary of the grant date.
/s/ William L. Demers, by Power of Attorney for Bridget A. Martell
2023-06-14